Diptheria Pertussis Tetanus (dpt)vaccine bulk supplier for pharma manufacturers

Diptheria Pertussis Tetanus (Dpt)Vaccine Suppliers & Bulk Manufacturers

Available Forms: Injection

Available Strengths: Diph. toxoid: ≥ 30 International Units ; Tetanus toxoid: ≥ 40 International Units

Reference Brands: Daptacel®, Infanrix®(US); Boostrix® ,Tripedia® (EU)

Category: Hepatitis

DPT vaccine injection typically contains ≥30 IU diphtheria toxoid, ≥40 IU tetanus toxoid, and either whole-cell or acellular pertussis antigens per 0.5 mL dose. This combination ensures effective protection against diphtheria, pertussis, and tetanus in infants and children.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description: The Diphtheria, Pertussis, Tetanus (DPT) vaccine injection is a combined immunization product providing protection against three serious bacterial diseases. It contains standardized doses of diphtheria toxoid (≥30 IU), tetanus toxoid (≥40 IU), and whole-cell or acellular pertussis antigens per 0.5 mL dose. Administered intramuscularly, it is essential in pediatric vaccination schedules to prevent diphtheria, whooping cough, and tetanus. Manufactured under stringent EU-GMP and USFDA standards, the DPT vaccine is widely supplied for hospital tenders, public health programs, and B2B distribution in the EU and US markets, supporting immunization coverage worldwide.

Diptheria Pertussis Tetanus (Dpt)Vaccine — third party manufacturing & bulk supply

Diptheria Pertussis Tetanus (Dpt)Vaccine is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Diptheria Pertussis Tetanus (Dpt)Vaccine is supplied as Injection — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Diptheria Pertussis Tetanus (Dpt)Vaccine listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Diptheria Pertussis Tetanus (Dpt)Vaccine →

Back to Listing

Frequently Asked Questions

Diptheria Pertussis Tetanus (dpt)vaccine is listed as Injection in Diph. toxoid: ≥ 30 International Units ; Tetanus toxoid: ≥ 40 International Units. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Diptheria Pertussis Tetanus (dpt)vaccine is referenced against Daptacel®, Infanrix®(US); Boostrix® ,Tripedia® (EU). Reference brands are shown for identification only and remain the property of their respective trademark owners.